End TB Clin.Trial Output 2

  • 1 A1: Web of Science-article

Search results

  • 2021

    Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

    Guglielmetti, L., Ardizzoni, E., Atger, M., Baudin, E., Berikova, E., Bonnet, M., Chang, E., Cloez, S., Coit, J. M., Cox, J., de Jong, B. C., Delifer, C., Do, J. M., Tozzi, D. D. S., Ducher, Ferlazzo, G., Gouillou, M., Khan, A., Khan, U. & Lachenal, N. & 24 others, LaHood, A. N., Lecca, L., Mazmanian, M., McIlleron, H., Moschioni, M., O'Brien, K., Okunbor, O., Oyewusi, L., Panda, S., Patil, S. B., Phillips, P. P. J., Pichon, L., Rupasinghe, P., Rich, M. L., Saluhuddin, N., Seung, K. J., Tamirat, M., Trippa, L., Cellamare, M., Velasquez, G. E., Wasserman, S., Zimetbaum, P. J., Varaine, F. & Mitnick, C. D., 2021, In: Trials. 22, 1, 15 p., 651.

    Research output: Contribution to journal › A1: Web of Science-article › peer-review

    Open Access
    File
    79 Downloads (Pure)